These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
300 related articles for article (PubMed ID: 23729002)
1. Teduglutide: a review of its use in the treatment of patients with short bowel syndrome. Burness CB; McCormack PL Drugs; 2013 Jun; 73(9):935-47. PubMed ID: 23729002 [TBL] [Abstract][Full Text] [Related]
2. Teduglutide: a guide to its use in short bowel syndrome. McKeage K Clin Drug Investig; 2015 May; 35(5):335-40. PubMed ID: 25859983 [TBL] [Abstract][Full Text] [Related]
3. Teduglutide: A Review in Short Bowel Syndrome. Kim ES; Keam SJ Drugs; 2017 Mar; 77(3):345-352. PubMed ID: 28194723 [TBL] [Abstract][Full Text] [Related]
4. Quality of life in patients with short bowel syndrome treated with the new glucagon-like peptide-2 analogue teduglutide--analyses from a randomised, placebo-controlled study. Jeppesen PB; Pertkiewicz M; Forbes A; Pironi L; Gabe SM; Joly F; Messing B; Loth S; Youssef NN; Heinze H; Berghöfer P Clin Nutr; 2013 Oct; 32(5):713-21. PubMed ID: 23587733 [TBL] [Abstract][Full Text] [Related]
5. Teduglutide reduces need for parenteral support among patients with short bowel syndrome with intestinal failure. Jeppesen PB; Pertkiewicz M; Messing B; Iyer K; Seidner DL; O'keefe SJ; Forbes A; Heinze H; Joelsson B Gastroenterology; 2012 Dec; 143(6):1473-1481.e3. PubMed ID: 22982184 [TBL] [Abstract][Full Text] [Related]
6. Factors Associated With Response to Teduglutide in Patients With Short-Bowel Syndrome and Intestinal Failure. Jeppesen PB; Gabe SM; Seidner DL; Lee HM; Olivier C Gastroenterology; 2018 Mar; 154(4):874-885. PubMed ID: 29174926 [TBL] [Abstract][Full Text] [Related]
7. Long-Term Therapy With Teduglutide in Parenteral Support-Dependent Patients With Short Bowel Syndrome: A Case Series. Ukleja A; To C; Alvarez A; Lara LF JPEN J Parenter Enteral Nutr; 2018 May; 42(4):821-825. PubMed ID: 29603279 [TBL] [Abstract][Full Text] [Related]
8. Randomised placebo-controlled trial of teduglutide in reducing parenteral nutrition and/or intravenous fluid requirements in patients with short bowel syndrome. Jeppesen PB; Gilroy R; Pertkiewicz M; Allard JP; Messing B; O'Keefe SJ Gut; 2011 Jul; 60(7):902-14. PubMed ID: 21317170 [TBL] [Abstract][Full Text] [Related]
9. New approaches to the treatments of short bowel syndrome-associated intestinal failure. Jeppesen PB Curr Opin Gastroenterol; 2014 Mar; 30(2):182-8. PubMed ID: 24406477 [TBL] [Abstract][Full Text] [Related]
10. Pharmacologic options for intestinal rehabilitation in patients with short bowel syndrome. Jeppesen PB JPEN J Parenter Enteral Nutr; 2014 May; 38(1 Suppl):45S-52S. PubMed ID: 24615689 [TBL] [Abstract][Full Text] [Related]
11. Teduglutide for the treatment of short bowel syndrome - a safety evaluation. Kochar B; Herfarth HH Expert Opin Drug Saf; 2018 Jul; 17(7):733-739. PubMed ID: 29848084 [TBL] [Abstract][Full Text] [Related]
12. Safety and Efficacy of Teduglutide (Gattex) in Patients With Crohn's Disease and Need for Parenteral Support Due to Short Bowel Syndrome-associated Intestinal Failure. Kochar B; Long MD; Shelton E; Young L; Farraye FA; Yajnik V; Herfarth H J Clin Gastroenterol; 2017 Jul; 51(6):508-511. PubMed ID: 27433811 [TBL] [Abstract][Full Text] [Related]
13. Teduglutide for the treatment of short bowel syndrome. Jeppesen PB Drugs Today (Barc); 2013 Oct; 49(10):599-614. PubMed ID: 24191254 [TBL] [Abstract][Full Text] [Related]
14. Teduglutide improves liver chemistries in short bowel syndrome-associated intestinal failure: Post hoc analysis. Micic D; Robinson I; Kidd T; Terreri B; Raphael BP Nutr Clin Pract; 2024 Jun; 39(3):634-640. PubMed ID: 38491966 [TBL] [Abstract][Full Text] [Related]
15. Experience with teduglutide treatment for short bowel syndrome in clinical practice. Pevny S; Maasberg S; Rieger A; Karber M; Blüthner E; Knappe-Drzikova B; Thurmann D; Büttner J; Weylandt KH; Wiedenmann B; Müller VA; Bläker H; Pascher A; Pape UF Clin Nutr; 2019 Aug; 38(4):1745-1755. PubMed ID: 30145039 [TBL] [Abstract][Full Text] [Related]
16. Safety and Efficacy of Teduglutide in Pediatric Patients With Intestinal Failure due to Short Bowel Syndrome: A 24-Week, Phase III Study. Kocoshis SA; Merritt RJ; Hill S; Protheroe S; Carter BA; Horslen S; Hu S; Kaufman SS; Mercer DF; Pakarinen MP; Venick RS; Wales PW; Grimm AA JPEN J Parenter Enteral Nutr; 2020 May; 44(4):621-631. PubMed ID: 31495952 [TBL] [Abstract][Full Text] [Related]
17. Teduglutide, a glucagon-like peptide-2 analog for the treatment of gastrointestinal diseases, including short bowel syndrome. Yazbeck R Curr Opin Mol Ther; 2010 Dec; 12(6):798-809. PubMed ID: 21154171 [TBL] [Abstract][Full Text] [Related]
18. Single-Center Experience with the Use of Teduglutide in Adult Patients with Short Bowel Syndrome. Lam K; Schwartz L; Batisti J; Iyer KR JPEN J Parenter Enteral Nutr; 2018 Jan; 42(1):225-230. PubMed ID: 29505151 [TBL] [Abstract][Full Text] [Related]
19. Impact of Teduglutide on Quality of Life Among Patients With Short Bowel Syndrome and Intestinal Failure. Chen K; Mu F; Xie J; Kelkar SS; Olivier C; Signorovitch J; Jeppesen PB JPEN J Parenter Enteral Nutr; 2020 Jan; 44(1):119-128. PubMed ID: 31006876 [TBL] [Abstract][Full Text] [Related]
20. Six-month outcomes of teduglutide treatment in adult patients with short bowel syndrome with chronic intestinal failure: A real-world French observational cohort study. Joly F; Seguy D; Nuzzo A; Chambrier C; Beau P; Poullenot F; Thibault R; Armengol Debeir L; Layec S; Boehm V; Lallemand J; Quilliot D; Schneider SM Clin Nutr; 2020 Sep; 39(9):2856-2862. PubMed ID: 31932048 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]